HAROLD E. SELICK - 28 Apr 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Harold E. Selick
Issuer symbol
PTGX
Transactions as of
28 Apr 2025
Net transactions value
+$12,441
Form type
4
Filing time
30 Apr 2025, 16:45:59 UTC
Previous filing
06 Jan 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $12,441 +10,725 +32% $1.16 43,851 28 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -10,725 -100% $0.000000 0 28 Apr 2025 Common Stock 10,725 $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options are fully vested.